What is the recommended dosage of Macrobid (nitrofurantoin) for a pregnant woman with an uncomplicated urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid Dosing in Pregnancy

Nitrofurantoin (Macrobid) 100 mg twice daily for 7 days is the recommended regimen for treating uncomplicated urinary tract infections in pregnant women, though it should be avoided in the first trimester and near term (after 38 weeks gestation) due to theoretical risks. 1

Standard Dosing Regimen for Pregnant Women

  • The recommended dose is nitrofurantoin 100 mg orally twice daily for 7 days for treatment of asymptomatic bacteriuria or symptomatic UTI in pregnancy. 1
  • A 1-day regimen (100 mg twice daily for 1 day) is significantly inferior to the 7-day regimen, with cure rates of only 75.7% versus 86.2%, and should not be used. 1
  • The 7-day duration is critical in pregnancy—shorter courses result in lower cure rates, lower birth weights, and earlier gestational age at delivery. 1

Critical Timing Considerations in Pregnancy

  • Avoid nitrofurantoin in the first trimester when possible, as this is the period of organogenesis, though retrospective data from 91 pregnancies showed no evidence of fetal toxicity or increased malformations. 2
  • Absolutely contraindicated after 38 weeks gestation and during labor/delivery due to theoretical risk of hemolytic anemia in the newborn (though this has not been definitively proven in clinical practice). 3, 2
  • The safest window for use is during the second trimester and early third trimester (weeks 14-38). 3

Why Nitrofurantoin Remains Preferred in Pregnancy

  • Nitrofurantoin has a 35+ year safety record in pregnancy with no documented R-factor resistance, making it superior to many newer antimicrobials. 3
  • Retrospective analysis of 91 pregnancies treated with nitrofurantoin showed no significant difference in fetal death, neonatal death, malformations, prematurity, low birth weight, low Apgar scores, or jaundice compared to the general U.S. population. 2
  • No abnormal events in these pregnancies were considered drug-related. 2

Alternative Agents When Nitrofurantoin Cannot Be Used

  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days can be used in the second trimester only (avoid in first trimester due to neural tube defect risk and in third trimester due to kernicterus risk). 4, 5
  • Fosfomycin 3 g single dose is an alternative, though it has slightly lower efficacy than nitrofurantoin (58% vs 70% clinical resolution). 6, 5
  • Beta-lactams (amoxicillin-clavulanate, cephalexins) are generally safe throughout pregnancy but have higher resistance rates. 3

Renal Function Precautions

  • Check creatinine clearance before prescribing—nitrofurantoin is contraindicated if CrCl <60 mL/min due to inadequate urinary concentrations and increased toxicity risk. 7
  • This is particularly important in pregnancy-related renal changes or preeclampsia. 7

Common Pitfalls to Avoid

  • Do not use single-dose or 3-day regimens in pregnancy—the 7-day course is essential for adequate cure rates and preventing adverse pregnancy outcomes. 1
  • Do not prescribe near term (>38 weeks)—switch to alternative agents if UTI develops close to delivery. 3, 2
  • Do not use for pyelonephritis—nitrofurantoin does not achieve adequate renal tissue concentrations; use IV ceftriaxone or gentamicin instead. 7, 5
  • Nausea occurs in 3% of patients; taking with food may reduce this side effect. 6

References

Research

Nitrofurantoin: an update.

Obstetrical & gynecological survey, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Macrobid Dosing for Uncomplicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What antibiotic is most effective for treating urinary frequency and pelvic pressure in urinary tract infections (UTIs)?
Is Nitrofurantoin (100 mg, 6-hourly, for 5 days) safe for treating lower urinary tract infections (UTIs) during pregnancy?
What is the best treatment for a 79-year-old female with urinary frequency symptoms and a confirmed Urinary Tract Infection (UTI) based on the presence of nitrites and bacteria in her Urine Analysis (UA)?
What is the best course of action for a post-menopausal patient with recurrent UTIs, currently on Macrobid (Nitrofurantoin), with urinalysis showing positive nitrates, leukocytes, and blood?
What's the management for a 10-week pregnant patient with urinary frequency, dysuria, positive nitrate test, and leucocyte esterase 3+ on dipstick, considering Nitrofurantoin (Nitrofurantoin) or Trimethoprim?
Can high cholesterol cause leg pain in patients with peripheral artery disease (PAD)?
What are the appropriate evaluation and treatment strategies for an older adult patient with elevated post void volume and a history of urinary tract issues?
Is Macrobid (nitrofurantoin) safe to use during pregnancy for a urinary tract infection (UTI)?
What is the best course of action for an adult patient with a history of mental health issues, currently experiencing emotional flattening while taking 150mg of Zoloft (sertraline)?
Can Aranesp (darbepoetin alfa) be administered immediately prior to blood transfusion in a patient with severe anemia?
What is the management for a non-displaced intra-articular fracture of the D1 (distal phalanx)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.